Barrow, Hanley, Mewhinney & Strauss’s Humana HUM Stock Holding History
Bought
Maintained
Sold
Other funds holding HUM
SC
Barrow, Hanley, Mewhinney & Strauss's HUM Position: Q2 2026 in Review
Barrow, Hanley, Mewhinney & Strauss increased its Humana (HUM) stake by 46% in Q2 2026, buying an estimated $70.9M and bringing the position to 792,814 shares worth $315M. The position accounts for 0.95% of the portfolio, ranked #39.
Barrow, Hanley, Mewhinney & Strauss first reported a position in HUM in Q2 2020 and has held it in 25 quarters since. The position peaked at $320M in Q2 2022. 924 funds tracked by Wall St. Rank hold HUM as of Q2 2026.
- Barrow, Hanley, Mewhinney & Strauss held 792,814 shares of Humana worth $315M as of Q2 2026.
- Barrow, Hanley, Mewhinney & Strauss bought 248,951 Humana shares in Q2 2026, an estimated $70.9M.
- Humana made up 0.95% of Barrow, Hanley, Mewhinney & Strauss's portfolio in Q2 2026, its #39 holding.
- Barrow, Hanley, Mewhinney & Strauss first reported a position in Humana in Q2 2020 and has held it in 25 quarters since.
- Barrow, Hanley, Mewhinney & Strauss's Humana position peaked at $320M in Q2 2022.
- 924 funds tracked by Wall St. Rank held Humana as of Q2 2026.
Based on Barrow, Hanley, Mewhinney & Strauss's 13F filing for Q2 2026, filed 12 Aug 2026.